消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2020 ESPEN指南：急慢性胰腺炎的临床营养

2020-01-22 欧洲临床营养和代谢学会 Clin Nutr. 2020 Jan 22.

急性胰腺炎慢性胰腺炎临床营养

2020年1月，欧洲临床营养和代谢学会(ESPEN)发布了急慢性胰腺炎的临床营养指南，急性和慢性胰腺炎均为胰腺的常见疾病，尽管为良性疾病，但存在严重营养不良的风险，可能需要营养支持治疗。本文主要针对急慢性胰腺炎的临床营养提供指导建议。

中文标题：

2020 ESPEN指南：急慢性胰腺炎的临床营养

英文标题：

ESPEN guideline on clinical nutrition in acute and chronic pancreatitis.

发布机构：

欧洲临床营养和代谢学会

发布日期：

2020-01-22

简要介绍：

2020年1月，欧洲临床营养和代谢学会(ESPEN)发布了急慢性胰腺炎的临床营养指南，急性和慢性胰腺炎均为胰腺的常见疾病，尽管为良性疾病，但存在严重营养不良的风险，可能需要营养支持治疗。本文主要针对急慢性胰腺炎的临床营养提供指导建议。

 

拓展指南：与急性胰腺炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 ESPEN指南：急慢性胰腺炎的临床营养)] GetToolGuiderByIdResponse(projectId=1, id=66dbf1c001862996, title=2020 ESPEN指南：急慢性胰腺炎的临床营养, enTitle=ESPEN guideline on clinical nutrition in acute and chronic pancreatitis., guiderFrom=Clin Nutr. 2020 Jan 22., authorId=null, author=, summary=2020年1月，欧洲临床营养和代谢学会(ESPEN)发布了急慢性胰腺炎的临床营养指南，急性和慢性胰腺炎均为胰腺的常见疾病，尽管为良性疾病，但存在严重营养不良的风险，可能需要营养支持治疗。本文主要针对急慢性胰腺炎的临床营养提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=374, associationName=欧洲临床营养和代谢学会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jan 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月，欧洲临床营养和代谢学会(ESPEN)发布了急慢性胰腺炎的临床营养指南，急性和慢性胰腺炎均为胰腺的常见疾病，尽管为良性疾病，但存在严重营养不良的风险，可能需要营养支持治疗。本文主要针对急慢性胰腺炎的临床营养提供指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>急性胰腺炎</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=28e151c00183a35b" title="中国急性胰腺炎诊治指南（2019·沈阳）" target=_blank>中国急性胰腺炎诊治指南（2019·沈阳）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ac82e1c001805e6f" title="WSES 重症急性胰腺炎管理指南（2019）解读" target=_blank>WSES 重症急性胰腺炎管理指南（2019）解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=22dc01c001590ea6" title="《2018年北美小儿胃肠病、肝脏病和营养胰腺学会临床报告：儿童急性胰腺炎的管理》摘译" target=_blank>《2018年北美小儿胃肠病、肝脏病和营养胰腺学会临床报告：儿童急性胰腺炎的管理》摘译</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5b7821c001590580" title="《2018年美国胃肠病学会指南：急性胰腺炎的初期处理》摘译" target=_blank>《2018年美国胃肠病学会指南：急性胰腺炎的初期处理》摘译</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b7b591c001555009" title="2018 NASPGHAN临床报告：儿童人群急性胰腺炎的管理" target=_blank>2018 NASPGHAN临床报告：儿童人群急性胰腺炎的管理</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E6%80%A5%E6%80%A7%E8%83%B0%E8%85%BA%E7%82%8E" target=_blank>有关急性胰腺炎更多指南</a></ul>, tagList=[TagDto(tagId=322, tagName=急性胰腺炎), TagDto(tagId=14127, tagName=慢性胰腺炎), TagDto(tagId=38406, tagName=临床营养)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11685, appHits=596, showAppHits=30, pcHits=2868, showPcHits=10075, likes=37, shares=31, comments=16, approvalStatus=1, publishedTime=Fri Feb 14 16:30:29 CST 2020, publishedTimeString=2020-01-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Feb 14 16:30:29 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:45:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 ESPEN指南：急慢性胰腺炎的临床营养)])
2020 ESPEN指南：急慢性胰腺炎的临床营养
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=977366, encodeId=5ee09e736691, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/8180c576616c46459e6f5338c2484d14/0fba824aeab3461e9e11714a64b2b8a4.jpg, createdBy=cefd5535266, createdName=ms6000000724836118, createdTime=Sun Jun 27 17:41:07 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959692, encodeId=06599596920c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 09:54:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951527, encodeId=707d95152e49, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6yNxBXT4JYjZW1IQ3cobmBdIZeBS3URH8QFdMicNs89PwCT8QOTUdtiakoLp2c6vRyqnicLPV4jsEuQbUEyuuIy8g/132, createdBy=0b712392119, createdName=zsl00, createdTime=Sat Mar 27 08:18:00 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925152, encodeId=d13092515262, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210217/108ada2b50124c0a837596be54fe3d3c/cde339817658438f91e2661bea5697b2.jpg, createdBy=46435264633, createdName=yeah, createdTime=Wed Feb 17 22:30:37 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917332, encodeId=528391e33240, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3085442418, createdName=ms8000001362071824, createdTime=Sun Jan 17 09:17:37 CST 2021, time=2021-01-17, status=1, ipAttribution=)]
    2021-06-27 ms6000000724836118

    赞👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=977366, encodeId=5ee09e736691, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/8180c576616c46459e6f5338c2484d14/0fba824aeab3461e9e11714a64b2b8a4.jpg, createdBy=cefd5535266, createdName=ms6000000724836118, createdTime=Sun Jun 27 17:41:07 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959692, encodeId=06599596920c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 09:54:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951527, encodeId=707d95152e49, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6yNxBXT4JYjZW1IQ3cobmBdIZeBS3URH8QFdMicNs89PwCT8QOTUdtiakoLp2c6vRyqnicLPV4jsEuQbUEyuuIy8g/132, createdBy=0b712392119, createdName=zsl00, createdTime=Sat Mar 27 08:18:00 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925152, encodeId=d13092515262, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210217/108ada2b50124c0a837596be54fe3d3c/cde339817658438f91e2661bea5697b2.jpg, createdBy=46435264633, createdName=yeah, createdTime=Wed Feb 17 22:30:37 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917332, encodeId=528391e33240, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3085442418, createdName=ms8000001362071824, createdTime=Sun Jan 17 09:17:37 CST 2021, time=2021-01-17, status=1, ipAttribution=)]
    2021-04-23 海明明

    棒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=977366, encodeId=5ee09e736691, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/8180c576616c46459e6f5338c2484d14/0fba824aeab3461e9e11714a64b2b8a4.jpg, createdBy=cefd5535266, createdName=ms6000000724836118, createdTime=Sun Jun 27 17:41:07 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959692, encodeId=06599596920c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 09:54:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951527, encodeId=707d95152e49, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6yNxBXT4JYjZW1IQ3cobmBdIZeBS3URH8QFdMicNs89PwCT8QOTUdtiakoLp2c6vRyqnicLPV4jsEuQbUEyuuIy8g/132, createdBy=0b712392119, createdName=zsl00, createdTime=Sat Mar 27 08:18:00 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925152, encodeId=d13092515262, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210217/108ada2b50124c0a837596be54fe3d3c/cde339817658438f91e2661bea5697b2.jpg, createdBy=46435264633, createdName=yeah, createdTime=Wed Feb 17 22:30:37 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917332, encodeId=528391e33240, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3085442418, createdName=ms8000001362071824, createdTime=Sun Jan 17 09:17:37 CST 2021, time=2021-01-17, status=1, ipAttribution=)]
    2021-03-27 zsl00

    太好了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=977366, encodeId=5ee09e736691, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/8180c576616c46459e6f5338c2484d14/0fba824aeab3461e9e11714a64b2b8a4.jpg, createdBy=cefd5535266, createdName=ms6000000724836118, createdTime=Sun Jun 27 17:41:07 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959692, encodeId=06599596920c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 09:54:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951527, encodeId=707d95152e49, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6yNxBXT4JYjZW1IQ3cobmBdIZeBS3URH8QFdMicNs89PwCT8QOTUdtiakoLp2c6vRyqnicLPV4jsEuQbUEyuuIy8g/132, createdBy=0b712392119, createdName=zsl00, createdTime=Sat Mar 27 08:18:00 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925152, encodeId=d13092515262, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210217/108ada2b50124c0a837596be54fe3d3c/cde339817658438f91e2661bea5697b2.jpg, createdBy=46435264633, createdName=yeah, createdTime=Wed Feb 17 22:30:37 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917332, encodeId=528391e33240, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3085442418, createdName=ms8000001362071824, createdTime=Sun Jan 17 09:17:37 CST 2021, time=2021-01-17, status=1, ipAttribution=)]
    2021-02-17 yeah

    好文

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=977366, encodeId=5ee09e736691, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/8180c576616c46459e6f5338c2484d14/0fba824aeab3461e9e11714a64b2b8a4.jpg, createdBy=cefd5535266, createdName=ms6000000724836118, createdTime=Sun Jun 27 17:41:07 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959692, encodeId=06599596920c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/972f8c2f32a64cd28f904bad3945efc9/3d1556a9e54b4781a5f4968d888e5874.jpg, createdBy=5d015401562, createdName=海明明, createdTime=Fri Apr 23 09:54:31 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951527, encodeId=707d95152e49, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6yNxBXT4JYjZW1IQ3cobmBdIZeBS3URH8QFdMicNs89PwCT8QOTUdtiakoLp2c6vRyqnicLPV4jsEuQbUEyuuIy8g/132, createdBy=0b712392119, createdName=zsl00, createdTime=Sat Mar 27 08:18:00 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925152, encodeId=d13092515262, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210217/108ada2b50124c0a837596be54fe3d3c/cde339817658438f91e2661bea5697b2.jpg, createdBy=46435264633, createdName=yeah, createdTime=Wed Feb 17 22:30:37 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917332, encodeId=528391e33240, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3085442418, createdName=ms8000001362071824, createdTime=Sun Jan 17 09:17:37 CST 2021, time=2021-01-17, status=1, ipAttribution=)]
    2021-01-17 ms8000001362071824

    好文

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

中国急性胰腺炎诊治指南（2019·沈阳）

中华医学会消化病分会（胰腺疾病学组） · 2019-10-30

《2018年美国胃肠病学会指南：急性胰腺炎的初期处理》摘译

暂未更新 · 2018-05-07

2018 AGA指南：急性胰腺炎的初期管理

美国胃肠病协会(AGA,American Gastroenterological Association) · 2018-02-03

急性胰腺炎中西医结合诊疗共识意见（2017年）

中国中西医结合学会消化系统疾病专业委员会 · 2017-12-30

JSHBPS指南：日本急性胰腺炎的管理（2015年）

日本肝胆胰腺外科学会(JSHBPS,Japanese Society of Hepato-Biliary-Pancreatic Surgery) · 2016-06-08

日本2015年急性胰腺炎治疗指南

日本儿科急诊学会(Japanese Society of Emergency Pediatrics) · 2016-04-21